Kyntra Bio to Report Second Quarter 2026 Financial Results
Kyntra Bio, Inc., a biopharmaceutical company, announced it will release its second quarter 2026 financial results on August 13, 2026, followed by a conference call with investors to discuss its corporate and financial performance. The company is focused on novel oncology and rare disease therapies, including the approved drug Roxadustat and the de…